Earnings season is in full bloom - Weekly Review, January 25-29

Earnings season is in full bloom - Weekly Review, January 25-29

Corporate earnings took the stage, overshadowing economic readings

Monday: TECH100 closed at a record high, after it went up 0.69%, as it eyed corporate earnings. However, the European markets closed lower, with Germany30 reporting one of the most significant decreases – 1.66% - as the country considered another national lockdown.

TSMC stock price gained 1.19% after the company announced that it would increase the auto chip production if possible, after talks with the country’s Minister Wang Mei-hua.

Seagate started the week on the wrong foot, as its stock price lost 6.3% after mixed quarterly earnings. The company reported an EPS of $1.29 on $2.62 billion revenues – a figure lower than that reported a year ago, $2.7 billion.

After the pandemic-induced demand for personal care products surged, Kimberly-Clark’s Q4 2020 earnings came in higher-than-expected. The EPS of $1.69 on $4.84 billion revenues translated to a stock price gain of 1.67%.

Tuesday: The Asian markets closed lower as the news of a delayed US stimulus package travelled across the ocean. Japan225 lost 0.82%, while HongKong45 slipped 2.31%.

The Italian Prime Minister Giuseppe Conte was set to hand in his resignation after COVID-19 criticism despite having government’s vote of confidence. Markets slightly reacted to the news, Italy40 adding 0.21%, while EUR/USD was at 1.2128.

UBS, the largest wealth manager in the world, posted higher-than-expected Q4 2020 figures. In the past quarter, the bank had a net income of $1.71 billion. So far, its stock price is up 3%.

JNJ stock price gained 2% after it reported quarterly figures higher than the EPS and revenues consensus. In Q4, Johnson & Johnson had an EPS of $1.86 on revenues of $22.48 billion.

Wednesday: As the FED announced that it would keep the monetary policies unchanged, the stocks had a most significant one-day percentage drop in three months. USA30 lost 2.05%, while USA500 lost 2.57%. Gold settled at $1,844.90 per ounce after it traded 0.3% lower.

Microsoft’s actual fiscal second-quarter figures and guidance beat expectations. The tech behemoth reported an adjusted EPS of $2.03 on revenues of $43.08 billion. It expected its revenues to reach $41.25 billion. Following the news, Microsoft stock price added 1.22%.

AMD stock price traded 0.62% higher after it reported an adjusted EPS of $0.52 on revenues of $3.24 billion. Both figures topped the market consensus.

Even though it had a mixed earnings report, Starbucks stock price closed 1.20% higher. It reported an EPS of $0.61 on revenues of $6.75 billion. The latter missed the $6.93 billion mark expected.

Thursday: Two new IPOs were ready to hit the markets: Qualtrics, and Ortho Clinical Diagnostics. Read more about them here!

The weekly number of unemployment claims came in lower-than-expected at 847,000. The market was looking for 880,000 people to be jobless in the week ended January 23.

According to the Bureau of Economic Analysis, the US GDP increased 4% in the final quarter of 2020, lower than the 4.2% expected.

The results didn’t go unnoticed by the markets, Crude oil trading 0.7% lower at $52.50 per barrel, and Brent falling 0.6% to $55.20 a barrel.

Friday: For the fiscal first quarter, Visa had an EPS of $1.42 on revenues of $5.69 billion, both figures coming ahead of the consensus. After the news hit the wires, the company’s stock price added 0.9%.

Qualtrics, one of the latest companies to become a publicly traded one surged on its NASDAQ debut. The company closed the trading session 52% higher than its initial offering price, reaching a $27.3 billion market valuation.

Johnson & Johnson ended the week 4% lower as it turned out its COVID-19 vaccine is overall only 66% effective against COVID-19.

On the other hand, Novavax revealed that its vaccine candidate is 89% effective, pushing the stock price 23% higher following the news.

Find out more on CAPEX.com!

Sources: cnbc.com, forexfactory.com, investing.com, reuters.com

Die hier präsentierten Informationen wurden von CAPEX.com erstellt und sind nicht als Investitionsberatung gedacht. Die hierin enthaltenen Informationen werden als allgemeine Marketingmitteilung nur zu Informationszwecken bereitgestellt. Als solche wurden sie nicht in Verbindung mit gesetzlichen Bestimmungen zur Förderung der Unabhängigkeit des Investment Research erstellt. Sie unterliegen nicht dem Verbot, vor der Verbreitung eines Investment Research gehandelt zu werden.

Die Benutzer / Die Leser sollten sich nicht nur auf die hier präsentierten Informationen verlassen und sollten ihre eigene Forschung / Analyse durchführen, indem sie auch die eigentliche zugrunde liegende Forschung lesen.Der Inhalt ist dabei generisch und wird nicht die individuelle persönliche Umstände,Anlageerfahrungen oder die aktuelle finanzielle Situationen berücksichtigten.

Daher übernimmt Key Way Investments Ltd keine Haftung für Verluste von Händlern aufgrund der Verwendung und des Inhalts der hierin enthaltenen Informationen. Die Wertentwicklung der Vergangenheit ist kein verlässlicher Indikator für zukünftige Ergebnisse.